Table 1.
Motivational interviewing case management genotyping of the cases
|
Number
|
Age
|
Sex
|
FABtyping
|
Karyotype
|
Immunological phenotype
|
Genemutation
|
Therapeutic reaction
|
Prognosis
|
Ref.
|
| 1 | 27 | F | M3 | i(17)(q10) | CD33+/CD13+/ MPO | PML-RARa (-) | Retinoic acid (-) | Die (survival 1 mo) | Yan et al[15], China |
| 2 | 10 | M | M3 | i(17)(q10) | - | - | NR | Die (survival < 1 mo) | Bernstein et al[14], South Africa |
| 3 | Child | F | - | i(17)(q10) | - | - | - | - | Raimondi et al[13], Mexico |
| 4 | - | - | M3 | i(17)(q10) | - | - | - | - | Becher et al[19] |
| 5 | 3 (Case 1) | M | M3 | i(17)(q10) | CD9/CD13/CD33/ CD38/CD64/CD123/CD58/MPO | WT1/EP300/C.854delG: P w285fs Frame shiftC.C2102T: P.701LMissense | - | Wen JQ, China | |
| 6 | 12 (Case 2) | M | M3 | i(17)(q10) Add(14) (p11) | CD9/CD13/CD33/ CD38/CD64/CD123/CD15/MPO | WT1/TAL1/TTN/DDX11 | + | CR 36 months, WT1 copy: 1010-1087 | Wen JQ, China |
F: Female; M: Male.